4-(Arylamino)phenyl α-d-glucopyranosides as potential anti-HIV agents
✍ Scribed by Josie C. Briggs; Alan H. Haines
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 446 KB
- Volume
- 282
- Category
- Article
- ISSN
- 0008-6215
No coin nor oath required. For personal study only.
✦ Synopsis
Our recent interest in aryl-substituted phenyl C~-D-glucopyranosides as potential anti-HIV agents [I-3] led us to examine 4-(arylamino)phenyl a-o-glucopyranosides (1) in this context, since we regarded these glycosides as a logical modification of 4-(arylsulfonylamino)phenyl a-D-glucopyranosides (2), one of which had been shown [3] to possess weak anti-HIV activity against HIV-I ilIB in infected cell cultures. Glycosides of the type 2 were found [3] to be remarkably eflective competitive inhibitors of yeast ¢:e-t)-glucosidase, an observation of relevance in regard to .'mti-HIV activity since nojirimycin, castanosperlnine, and some of their deriwltives which show such antivirai activity also act competitively against certain glycosidases [4]. We now report the synthesis of a series of glycosides 3=6 and some representative examples of lipophilic O-acyl derivatives, compounds 711t), and results of anti.HIV tests with these compounds.
📜 SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Novel 2‐(coumarin‐4‐yloxy)‐4,6‐(substituted)‐s‐triazine derivatives __i. e.,__ diaryltriazine (DATA) are reported as novel non‐nucleoside reverse transcriptase inhibitors (NNRTIs), were synthesized and their activities against human immunodeficiency virus HIV‐1 (III‐B), HIV‐2 (ROD), and